VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 215 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,283,193 | +330.3% | 136,947 | +968.6% | 0.01% | +350.0% |
| Q1 2023 | $298,205 | -39.4% | 12,815 | -34.1% | 0.00% | -33.3% |
| Q4 2022 | $492,457 | -75.8% | 19,457 | -81.6% | 0.00% | -72.7% |
| Q3 2022 | $2,034,000 | -51.9% | 105,507 | -36.4% | 0.01% | -57.7% |
| Q2 2022 | $4,227,000 | +2.4% | 165,941 | +3.4% | 0.03% | -25.7% |
| Q1 2022 | $4,128,000 | +8.5% | 160,503 | +76.6% | 0.04% | -2.8% |
| Q4 2021 | $3,806,000 | +1392.5% | 90,899 | +1450.1% | 0.04% | +1100.0% |
| Q3 2021 | $255,000 | -83.0% | 5,864 | -81.5% | 0.00% | -82.4% |
| Q2 2021 | $1,499,000 | +81.7% | 31,706 | +96.9% | 0.02% | +54.5% |
| Q1 2021 | $825,000 | – | 16,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |